Friedrich Graf Finckenstein M.D.

Friedrich Graf Finckenstein M.D.

Company: Iovance Biotherapeutics

Job title: Chief Medical Officer

Seminars:

The Evolution of Clinical Development for TIL Cell Therapy in Solid Tumors 9:30 am

Delivering broader access to TIL through multi-center studies and scalable manufacturing Clinical Data for TIL in metastatic melanoma, metastatic non-small cell lung and advanced cervical cancers Clinical data for TIL in combination with other therapies in earlier cancer treatment settings Research on genetically-modified TIL as a next-generation approachRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.